Also, IL-10 and IL-13 alterations in brain appear specific to AD, and not Parkinson’s disease (PD) or Dementia with Lewy Bodies, which have separate immunologic signatures (Chai et al., 2023), and could prove interesting as future differential biomarkers for these conditions. The gene discussed is IL10; the disease is Alzheimer disease.